Drug Reference
Amylase / Lipase / Protease
Brand names
CreonPanaKarePancrePlusPancreazePertzyeViokaceZenpep
Available as
15000 UNT · Oral Capsule78300 UNT · Oral Tablet39150 UNT · Oral Tablet60500 UNT · Oral Capsule30250 UNT · Oral Capsule180000 UNT · Oral Capsule64000 UNT · Oral Tablet164 UNT/MG · Powder15125 UNT · Oral Capsule105000 UNT · Oral Capsule14000 UNT · Oral Capsule24000 UNT · Oral Capsule42000 UNT · Oral Capsule63000 UNT · Oral Capsule84000 UNT · Oral Capsule61500 UNT · Oral Capsule98400 UNT · Oral Capsule83900 UNT · Oral Capsule24600 UNT · Oral Capsule90750 UNT · Oral Capsule168000 UNT · Oral Capsule20000 UNT · Oral Capsule112500 UNT · Oral Capsule58500 UNT · Oral Capsule
Multi-ingredient product
AmylaseLipaseProtease
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- PANCREATIC ENZYME CONCENTRATE TABLET [COVETRUS NORTH AMERICA]
- ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE) CAPSULE, DELAYED RELEASE [AIMMUNE THERAPEUTICS, INC.]
- CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS [ABBVIE INC.]
- VIOKACE (PANCRELIPASE) TABLET [AIMMUNE THERAPEUTICS, INC.]
- PANCREAZE (PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE) CAPSULE, DELAYED RELEASE [VIVUS LLC]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.